The Impact of Tofogliflozin on Physiological and Hormonal Function, Serum Electrolytes, and Cardiac Diastolic Function in Elderly Japanese Patients with Type 2 Diabetes Mellitus

Higashikawa, T; Ito, T; Mizuno, T; Ishigami, K; Kuroki, K; Maekawa, N; Usuda, D; Izumida, T; Yamada, S; Sangen, R; Hamada, K; Kiyosawa, J; Saito, A; Iguchi, M; Kasamaki, Y; Nakahashi, T; Fukuda, A; Saito, H; Kanda, T; Okuro, M

Higashikawa, T (通讯作者)，Kanazawa Med Univ, Himi Municipal Hosp, Himi, Toyama 9358531, Japan.;Higashikawa, T (通讯作者)，Kanazawa Med Univ, Dept Geriatr Med, Uchinada, Ishikawa 9200293, Japan.

ACTA MEDICA OKAYAMA, 2022; 76 (6): 705

Abstract

The sodium glucose transporter 2 (SGLT2) inhibitor tofogliflozin is a glucose-lowering drug that causes the excretion of surplus glucose by inhibiting......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索